Patrick Borgen, MD, shares his thoughts on the ethics and the efficacy of undergoing pre-emptive double mastectomy in women who have a BRCA mutation, which can greatly increase their risk for breast and ovarian cancers.
While studies show that preventive double mastectomies do not significantly improve survival rates, it does reduce risk of anxiety and number of physician visits. Patrick Borgen, MD, shares his thoughts on the ethics and the efficacy of undergoing pre-emptive double mastectomy in women who are BRCA-positive.
Traditional Definition of ‘High-Risk’ in Patients With CLL and SLL Outdated, Needs to be Revisited
December 7th 2020In an interview with CURE®, Dr. Jan A. Burger discusses how the results of two phase 3 studies could help redefine what constitutes as low or high risk in patients with CLL or SLL.
Read More
To gain a better understanding of the issues faced by geriatric patients with cancer, and to determine how much of a role nutrition plays in outcomes, Dr. Grant Williams, a geriatrician oncologist and assistant professor at the University of Alabama, Birmingham, worked with colleagues to create a patient-reported assessment tool that bridges the knowledge gap in this patient population.
Read More